TGA Internet site archive
The content on this page and other TGA archive pages is provided to assist research and may contain references to activities or policies that have no current application. See the full archive disclaimer.
Archived TGA publications & articles
- Amendments to the regulations, 2010 (23 June 2010)
- Applications for orphan drug designation (3 March 2016)
- ARGOM Appendix 1: Guidelines on efficacy and safety aspects of OTC applications (29 November 2015)
- ARGOM: Guidelines on changes to OTC medicines (29 November 2015)
- ARGOM: Guidelines on electronic OTC dossiers (29 November 2015)
- ARGOM: Guidelines on post-market surveillance (9 November 2012)
- ARGOM: Guidelines on route of evaluation (29 November 2015)
- ARGOM: Guidelines on the pre-market application and evaluation process for OTC medicines (29 November 2015)
- AusPAR project (24 August 2010)
- Australia New Zealand Therapeutic Products Agency (ANZTPA)
- Australian code of GMP for human blood and tissues (2000) (24 August 2000)
- Australian code of GMP for therapeutic goods - sunscreen products (1994) (1 February 1994)
- Australian code of good manufacturing practice for medicinal products (16 August 2002) (16 August 2002)
- Australian code of good wholesaling practice for therapeutic goods for human use (1 November 1991)
- Australian pharmacovigilance requirements and recommendations for medicine sponsors (12 November 2013)
- Australian Public Assessment Report (AusPAR) guidance (25 October 2010)
- Australian regulatory guidelines for complementary medicines (ARGCM) (archived) (26 July 2012)
- Australian regulatory guidelines for OTC medicines (ARGOM) (29 November 2015)
- Australian regulatory guidelines for OTC medicines (ARGOM) (archived)
- Australian regulatory guidelines for OTC medicines (ARGOM) (Nov 2012) (9 November 2012)
- Australian regulatory guidelines for prescription medicines (ARGPM) (archived) (21 May 2013)
- Best practice guideline on prescription medicine labelling (17 November 2008)
- Better information on medicine labels - have your say (24 May 2012)
- Business rules for reduced assessment fees for IVDs (8 August 2012)
- Colourings permitted in medicines for oral use (4 May 2011)
- Common technical document (CTD) (28 April 2011)
- Cosmetic claims guidelines (9 May 1997)
- Evaluation of biosimilars (30 July 2013)
- Fees and charges for IVD medical devices (16 August 2010)
- Fifty years of independent expert advice on prescription medicines (12 February 2014)
- Guidance for industry on electronic prescription medicine submission dossiers (4 January 2011)
- Guidance on licensing/certification inspections (29 April 2013)
- Guidance on product changes in ELF3 (2008) (28 August 2008)
- Guidance on the use of the term 'Quantified by Input' for Listed complementary medicines (8 June 2005)
- Guide to interpretation of the Australian Code of Good Manufacturing Practice for Medicinal Products (16 August 2002) applicable to the manufacture of complementary medicines (1 December 2003)
- Guideline on prescription medicine discontinuations (17 October 2007)
- Guidelines for levels and kinds of evidence to support indications and claims
- Honey - scientific report (1 December 1998)
- Improved TGA website search engine (29 July 2014)
- Improving international cooperation between regulators (31 October 2011)
- Medical Officer vacancies at the TGA (23 March 2011)
- Medical products and the Internet
- Medicines information kit (1 November 1999)
- Medicines scheduling secretariat has moved to the TGA (11 September 2014)
- Minor variations to registered prescription medicines: Biological medicines (14 May 2013)
- Minor variations to registered prescription medicines: Chemical entities (14 May 2013)
- NCCTG scheduling policy framework (1 July 2010)
- Number of valid reports in adverse reactions database reaches 250,000 (4 April 2012)
- OTC application categorisation framework (22 March 2013)
- OTC dossier documents matrix (22 March 2013)
- Tamper-evident packaging guideline (22 December 2000)
- TGA biologicals framework newsletter
- TGA business plan 2012-2013 (7 November 2012)
- TGA business plan 2013-2014 (19 December 2013)
- TGA business plan 2014-2015 (25 November 2014)
- TGA business plan 2015-2016 (1 March 2016)
- TGA customer service charter (1 October 2010)
- TGA external communication and education framework (21 December 2012)
- TGA international engagement strategy 2013-2015 (1 August 2013)
- TGA international engagement strategy 2013-2015 (9 October 2014)
- TGA prescription medicines SSP newsletter (21 September 2012)
- TGA reforms: A blueprint for TGA's future (December 2011) (8 December 2011)
- Therapeutic Goods Amendment (2009 Measures No 1) Act 2009
- Therapeutic Goods Amendment (2009 Measures No 2) Act 2009
- Therapeutic Goods Amendment (2009 Measures No 3) Act 2010
- Therapeutic Goods Amendment (2010 Measures No 1) Bill 2010
- Therapeutic Goods Amendment (Medical Devices and Other Measures) Act 2009
- Upgrade to TGA website (23 October 2014)